[1]
Z. Song, “Daraxonrasib Treatment in RAS-Mutated Pancreatic Cancer: Mechanisms, Clinical Evidence and Future Perspectives”, TMBLS, vol. 9, pp. 89–96, Sep. 2026, doi: 10.62051/ndcdrx21.